Peter Hillmen, M.D., Ph.D. Pinderfields Hospital (United Kingdom)

Peter Hillmen is a Consultant Haematologist at the Leeds Teaching Hospitals NHS Trust and is based at St. James University Hospital in Leeds, UK. He obtained his medical degree from Leeds Medical School in 1985, followed by general medical training in Leeds. He then spent 2 years at Hammersmith Hospital training in haematology followed by 3 years researching under the supervision of Professor Lucio Luzzatto at the Royal Postgraduate Medical School. He was awarded a Ph.D. by the University of London for research into paroxysmal nocturnal haemoglobinuria (PNH), before completing his training in haematology in Leeds.

His clinical and research interests include chronic lymphocytic leukaemia (CLL) and PNH. He is Chairman of the CLL trials subgroup of the National Cancer Research Institute (NCRI), with the responsibility of developing a portfolio of phase II and III studies in CLL for the UK. Dr. Hillmen is also the Chairman of the International PNH Interest Group. He is principal investigator of several national and international phase II and III trials for CLL and PNH.

Dr. Hillmen is a member of the NCRI Haematological Oncology Clinical Studies Group, and a fellow of the Royal College of Pathologists and the Royal College of Physicians. He is also a member of the British Society for Haematology and the American Society of Hematology. He has published over 80 papers in peer-reviewed journals, including in the New England Journal of Medicine, Nature Medicine, the Proceedings of the National Academy of Sciences (USA), The Lancet and numerous papers in Blood. In addition, he has authored or co-authored several reviews and book chapters on the subjects of CLL and PNH.